Loading...
NEJM Group covered key research presented at CHEST 2022, including a study on biologic therapies used to treat asthma and atopic dermatitis. The study's lead author Martin C. Runnström, MD, and coauthor Pedro A. Lamothe, MD, PhD, discuss the clinical implications of their findings in an interview with Christine Sadlowski. Both are Pulmonary Critical Care fellows at Emory University School of Medicine in Atlanta. We encourage you to watch the interview.